BioCatalyst

PGEN — PRECIGEN, INC. catalysts

1 verified catalyst event(s) for PRECIGEN, INC. (ticker PGEN). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-11-11 — PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervi · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-11-11
in 5mo
ESTIMATED
 READOUT
PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metast
Phase 2 · Cervical Cancer, HPV-Related Carcinoma
 PGEN PRECIGEN, INC. PRGN-2009 plus Pembrolizumab ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.